BioMarin Pharmaceutical meets primary endpoint in Phase 3 study of VOXZOGO in children with hypochondroplasia

Hyundai Bioscience says XAFTY available for Ebola and Hantavirus treatment

4basebio secures clinical supply agreement for Phase II immunotherapy trial

FDA approves MEKanistic Therapeutics' IND for MTX-531

Sino Biological launches XPressMAX Cell-Free Protein Synthesis Kit

Matter Bio submits first IND application for Lm-LLO-TT

Myosin Therapeutics doses first patient in Phase 1/2 study of MT-125 in GBM

Nanjing Leads Biolabs receives Chinese approval for pivotal Phase III trial of PD-L1/4-1BB bispecific antibody

Accro Bioscience completes USD50m Series C financing

AstraZeneca wins US approval for Baxfendy as first aldosterone synthase inhibitor for hypertension

GSK's Arexvy gains expanded approval in Japan for at-risk adults aged 18-49

SciBase research highlights Nevisense potential in age-related skin analysis

Atisama Therapeutics reports progress in Phase 1 study of RB042

Racura Oncology reports positive Safety Review Committee recommendation in ongoing CPACS trial of RC220

Akeso reports results from Phase II trial of ligufalimab combination therapy in AML